| Literature DB >> 34736496 |
Haojie Pan1, Jia Wang1, Haoliang Wu1, Zhongjian Li1, Jiazhang Lian2,3.
Abstract
BACKGROUND: CO2 valorization is one of the effective methods to solve current environmental and energy problems, in which microbial electrosynthesis (MES) system has proved feasible and efficient. Cupriviadus necator (Ralstonia eutropha) H16, a model chemolithoautotroph, is a microbe of choice for CO2 conversion, especially with the ability to be employed in MES due to the presence of genes encoding [NiFe]-hydrogenases and all the Calvin-Benson-Basham cycle enzymes. The CO2 valorization strategy will make sense because the required hydrogen can be produced from renewable electricity independently of fossil fuels. MAIN BODY: In this review, synthetic biology toolkit for C. necator H16, including genetic engineering vectors, heterologous gene expression elements, platform strain and genome engineering, and transformation strategies, is firstly summarized. Then, the review discusses how to apply these tools to make C. necator H16 an efficient cell factory for converting CO2 to value-added products, with the examples of alcohols, fatty acids, and terpenoids. The review is concluded with the limitation of current genetic tools and perspectives on the development of more efficient and convenient methods as well as the extensive applications of C. necator H16.Entities:
Keywords: Biomanufacturing; CO2 conversion; Cupriviadus necator H16; Metabolic engineering; Ralstonia eutropha H16; Synthetic biology
Year: 2021 PMID: 34736496 PMCID: PMC8570001 DOI: 10.1186/s13068-021-02063-0
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1Overview of synthetic biology toolkit for C. necator H16 and microbial electrosynthesis (MES) system. A well-established MES system requires good coupling of C. necator with the electrolysis system and efficient CO2 conversion to value-added products. ORI: origin of replication
Genetic engineering vectors commonly used in C. necator
| Vectors | Description | Reference |
|---|---|---|
| pCM | RP4 ORI, low copy, ~ 8 | [ |
| pCM271 | RP4 ORI, mutation in | [ |
| pBBR1 | medium copy, ~ 40 | [ |
| pKT230 | RSF1010 ORI, medium copy, ~ 10 | [ |
| pSa | low copy, 2 ~ 3 | [ |
| pCUP3 | pMOL28 ORI, low copy, 1 | [ |
| pJQPPCm | [ | |
| pJV7 | [ | |
| pCB42 | [ | |
| pLH63 | [ | |
| pEX100T | [ | |
| pLO1 | [ | |
Screening markers available in C. necator
| Marker | Description | Reference |
|---|---|---|
| Resistant to kanamycin; 200–350 μg/mL | [ | |
| Resistant to tetracycline; 10–25 μg/mL | [ | |
| Resistant to chloramphenicol; 25–50 μg/mL | [ | |
| [ | ||
| [ | ||
| [ | ||
| [ | ||
| Lethal in sucrose-containing medium | [ | |
The antibiotic ranges to some extent is dependent on the culture conditions and drug manufacturers
Comparison of inducible promoters developed in C. necator
| Promoter | Inducer and concentration | Induction ratio | Effects on growth |
|---|---|---|---|
| AraC/P | 10 mM L-arabinose | 1200 | Inhibited cell growth; not consumed |
| RhaRS/P | 11 mM L-rhamnose | 1960 | Virtually not altered cell growth; not consumed |
| LacI/P | 1 mM IPTG | ~ 300 | Inhibited cell growth at high concentration; not consumed |
| PM/P | 1 mM m-toluic acid | ~ 300 | – |
| AcuR/P | 5 mM acrylate | 33 | Consumed |
| YpItcR/P | 5 mM itaconate | 105 | Not consumed |
| MmsR/P | 10 mM 3-hydroxypropionic acid | 51.5 | Growth-retarding effect at the beginning of cultivation; consumed |
| HpdR/P | 10 mM 3-hydroxypropionic acid | 516.6 | Growth-retarding effect at the beginning of cultivation; consumed |
| LacI/P | 1 mM IPTG | ~ 7 | Growth inhibition at high concentration; not consumed |
| CymR/P | 120 μM p-cumate | 22 | Nearly no effect on growth |
| TetR/P | 200 ng/mL anhydrotetracycline | ~ 1100 | No negative effect on growth; not consumed; antibiotic |
| TetR/P | 25 ng/mL doxycycline | ~ 180 | No negative effect on growth; not consumed; antibiotic |
The induction ratio is recalculated based on AraC/P as a benchmark according to references [47, 65, 71, 74, 78–80]
Fig. 2Genome editing tools developed in C. necator H16. a Target gene deletion via group II introns. b Target gene deletion via two rounds of single-crossover using kanR and sacB as selection and counter-selection markers, respectively. c Target gene deletion via double-crossover using kanR as a selection marker and maker recycling by the Cre/loxP system. d Target gene deletion via CRISPR/Cas9. DSB: double-strand break
Commonly used C. necator strains for different applications
| Genome description | Application | Reference | |
|---|---|---|---|
| H16PHB−4 | Chemical mutates | Value-added products | [ |
| H16Δ | Precisely constructed to block PHB synthesis | Value-added products | [ |
| H16Δ | Precisely constructed to block PHB synthesis | Value-added products | [ |
| H16 G+1 | UV mutates | Able to use glucose | [ |
| C5 | H16Δ | Improved electroporation efficiency | [ |
| Re2303 | H16Δ( | Fatty-acid derived fuels and chemicals | [ |
| BC4 | Mutant in | ROS-tolerant strain to be applied in MES | [ |
| v6C6 | Mutant in | Improved glycerol utilization | [ |
Products synthesized in C. necator from CO2
| Products | Vectors | Expression elements | Host | Fermentation conditions and titers (yields) | References |
|---|---|---|---|---|---|
| Acetoin | Plasmid ( | P | H16Δ | Gas fermentation 0.32 mol acetoin/mol CO2 | [ |
| 2,3-Butanediol | Integration ( | P | H16Δ | Gas fermentation 32.0 ± 0.1 g/L | [ |
| Isopropanol | Integration ( | P | H16Δ | Gas fermentation 7.7 ± 0.2 g/L | [ |
| Plasmid pEG7b ( | P | H16Δ | Gas fermentation 3.5 g/L | [ | |
| Plasmid pEG12 ( | P | H16Δ | MES 216 mg/L | [ | |
| Plasmid pEG12 ( | P | H16Δ | MES ~ 600 mg/L | [ | |
| Plasmid pLH205 ( | P | H16 | Formic acid 30 mg/L | [ | |
| Isobutanol and 3-methyl-1-butanol | Plasmid JL26 ( | P | DJ21Δ | MES ~ 220 mg/L | [ |
Integration ( plasmid pYL22 ( | int-P plasmid-P | H16Δ | MES 140 mg/L | [ | |
| Fatty acids | Plasmids pCT ( | pCT-P pFP-P | H16Δ | Gas fermentation 60.64 mg/g CDW | [ |
| Methyl ketones | Plasmid pJM20 ( | P | Re2303Δ | Gas fermentation 50 ~ 180 mg/L | [ |
| Alka(e)ne | Plasmid pLC10 ( | P | H16Δ | Gas fermentation 4.4 mg/L | [ |
| α-Humulene | Plasmid pKR-hum ( | P | H16PHB−4 | MES 17 mg/g CDW | [ |
| 2-Hydroxy isobutyric acid | Plasmid pHCM ( | P | H16PHB−4 | Gas fermentation 3.2 g/L | [ |
| Trehalose | Plasmid pSEVA228 ( | P | H16 | Gas fermentation 0.47 g/L | [ |
| Sucrose | Plasmid pBADT ( | P | H16 | Gas fermentation 180 mg/L | [ |
| Lipochitooligosaccharides | Plasmid pBADT ( | P | H16 | Gas fermentation 1.4 mg/L | [ |
| Lycopene | Plasmid ( | P | C5 | MES 1.73 mg/L | [ |
DJ21is an isobutanol tolerant strain with constitutive alcohol dehydrogenase activity constructed by Jendrossek et al. [150]
Fig. 3Schematic of the biosynthetic pathways for producing isopropanol, isobutanol, and 3-methyl-1-butanol in C. necator H16. The isopropanol pathway is shown in blue, two different isobutanol pathways in yellow, the 3-methyl-1-butanol pathway in orange, and the polyhydroxybutyrate pathway in white. Native genes are shown in blue, while heterologous genes are shown in red. IPA: isopropanol; IBT: isobutanol; 3MB: 3-methyl-1-butanol; PHB: polyhydroxybutyrate
Fig. 4Schematic of the biosynthetic pathways for producing fatty acids and derivatives in C. necator H16. Main related pathways include fatty acid biosynthesis, β-oxidation cycle, and PHB synthesis, with acetyl-CoA as a central building block. Heterologous genes to synthesize fatty acids, alkanes, and methyl ketones are shown in red. PHB: polyhydroxybutyrate
Fig. 5Schematic of the biosynthetic pathways for producing terpenoids in C. necator H16. Mevalonate (MVA, shown in blue) pathway and 2-C-methyl-D-erythritol-4-phosphate (MEP, shown in orange) pathway are two major pathways for terpenoid biosynthesis. Native genes are shown in blue, while heterologous genes are shown in red. HMG-CoA: 3-hydroxy-3-methyl glutaryl coenzyme A; MVA: mevalonic acid; PMVA: mevalonate-5-phosphate; DPMVA: mevalonate-5-pyrophosphate; DXP: 1-deoxy-D-xylulose-5-phosphate; MEP: 2-C-methyl-d-erythritol-4-phosphate; CDP-ME: 4-(cytidine 5′-diphospho)-2-C-methyl-d-erythrito; CDP-MEP: 4-(cytidine 5′-diphospho)-2-C-Methyl-d-erythritol-4-phosphate; MECPP: 2-C-methyl-d-erythritol-2,4-cyclodiphosphate; HMBPP: 1-hydroxy-2-meyhyl-2-butenyl-4-diphosphate; IPP: isopentenyl-5-pyrophosphate; DMAPP: dimethylallyl-pyrophosphate; GPP: geranyl-pyrophosphate; FPP: farnesyl-pyrophosphate